GLP-1 patches have emerged as a revolutionary option for those seeking effective management of obesity and diabetes
That's the most important. The doctor will ask about symptoms, medical history, and any underlying conditions, such as diabetes or neurological disorders
Sources / References The New England Journal of Medicine (NEJM) Phase 2 Trial (Primary Peer-Reviewed Study) Jastreboff AM, Kaplan LM, Fras JP, et al
doi: 10.1016/j.nutres.2022.03.002
Berberine 500mg + Curcumin 500mg + Chromium Picolinate 200mcg taken daily can yield 5-7lb loss plus A1C reduction of -0.9% through synergistic effects on insulin sensitivity and GLP-1 production
Pharma now needs to work hard to present a more complete picture of obesity management: where it fits within the pantheon of related metabolic and cardiovascular diseases, and how GLP-1s can still play a pivotal role in treatment, beyond weight loss alone